{"symbol":"ABT","fiscalQuarter":"Q3-2021","reportDate":"2021-10-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2021","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 3.33%","keyNumbers":[{"metric":"EPS","actual":"$1.40","expected":"N/A","surprise":"+51.84%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported a strong earnings per share figure that exceeded expectations significantly, leading to a positive stock reaction of 3.33%. However, there was no revenue data provided, which leaves some uncertainty about overall performance. Investors may view the EPS beat as a sign of operational strength, but the lack of additional context from management could lead to cautious sentiment moving forward.","metaDescription":"Abbott Laboratories (ABT) Q3 2021 earnings: EPS beat by 51.84%. Stock up 3.33%. Full breakdown."}}